A
Anushka Patel
Researcher at The George Institute for Global Health
Publications - 337
Citations - 29250
Anushka Patel is an academic researcher from The George Institute for Global Health. The author has contributed to research in topics: Diabetes mellitus & Type 2 diabetes. The author has an hindex of 69, co-authored 315 publications receiving 25272 citations. Previous affiliations of Anushka Patel include Northwestern University & Ministry of Health (New South Wales).
Papers
More filters
Journal ArticleDOI
Resting Heart Rate and the Risk of Microvascular Complications in Patients With Type 2 Diabetes Mellitus
Graham S. Hillis,Jun Hata,Mark Woodward,Vlado Perkovic,Hisatomi Arima,Clara K Chow,Sophia Zoungas,Anushka Patel,Neil R Poulter,Giuseppe Mancia,Bryan Williams,John Chalmers +11 more
TL;DR: Patients with type 2 diabetes mellitus who have a higher resting heart rate experience a greater incidence of new-onset or progressive nephropathy and retinopathy.
Journal ArticleDOI
Effects of Combination of Perindopril, Indapamide, and Calcium Channel Blockers in Patients With Type 2 Diabetes Mellitus Results From the Action in Diabetes and Vascular Disease: Preterax and Diamicron Controlled Evaluation (ADVANCE) Trial
John Chalmers,John Chalmers,John Chalmers,Hisatomi Arima,Hisatomi Arima,Hisatomi Arima,Mark Woodward,Mark Woodward,Mark Woodward,Giuseppe Mancia,Neil Poulter,Yoichiro Hirakawa,Yoichiro Hirakawa,Sophia Zoungas,Anushka Patel,Anushka Patel,Anushka Patel,Bryan Williams,Bryan Williams,Stephen B. Harrap +19 more
TL;DR: In this paper, the effects of a fixed combination of perindopril and indapamide in combination with calcium channel blockers (CCBs) in patients with type 2 diabetes mellitus were determined.
Journal ArticleDOI
A Randomised controlled trial of a consumer-focused e-health strategy for cardiovascular risk management in primary care : the Consumer Navigation of Electronic Cardiovascular Tools (CONNECT) study protocol
Julie Redfern,Tim Usherwood,Mark Harris,Anthony Rodgers,Noel Hayman,Kathryn S Panaretto,Clara K Chow,Annie Y. S. Lau,Lis Neubeck,Genevieve Coorey,Fred Hersch,Emma Heeley,Anushka Patel,Stephen Jan,Nicholas Zwar,David Peiris +15 more
TL;DR: Consumer Navigation of Electronic Cardiovascular Tools (CONNECT) aims to test whether a consumer-focused e-health strategy provided to Aboriginal and Torres Strait Islander and non-indigenous adults, recruited through primary care, at moderate-to-high risk of a cardiovascular disease event will improve risk factor control when compared with usual care.
Journal ArticleDOI
ADVANCE Action in Diabetes and Vascular Disease: patient recruitment and characteristics of the study population at baseline
Anushka Patel,Bruce Neal,John Chalmers,Stephen MacMahon,Simon Heller,C. Y. Pan,Mark Woodward,S. Coleman +7 more
TL;DR: The ADVANCE trial as discussed by the authors is a 2 × 2 factorial randomized controlled trial, where participants were randomized to perindopril/indapamide (initially 2.0/0.625 mg daily, increasing to 4.0 /1.25 mg daily after 3 months) or matching placebo; and to an intensive gliclazide MR-based glucose control regimen aiming for a haemoglobin A1c (HbA1c) value of 6.5% or lower, or local standard therapy.
Journal ArticleDOI
Efficacy and safety of routine blood pressure lowering in older patients with diabetes: Results from the advance trial
Toshiharu Ninomiya,Sophia Zoungas,Sophia Zoungas,Bruce Neal,Mark Woodward,Mark Woodward,Anushka Patel,Vlado Perkovic,Alan Cass,Mark E. Cooper,Diederick E. Grobbee,Pavel Hamet,Stephen B. Harrap,Lisheng Liu,Giuseppe Mancia,Carl Erik Mogensen,Neil R Poulter,Anthony Rodgers,Bryan Williams,Stephen MacMahon,John Chalmers +20 more
TL;DR: Routine administration of perindopril–indapamide lowers blood pressure safely and reduces the risk of major clinical outcomes in patients of at least 75 years with type 2 diabetes.